Dr. Steve Orndorff
Dr. Steve Orndorff has been named CEO at MicroBiome Therapeutics – the new name for NuMe Health.
Orndorff was CEO of Ariel Pharmaceuticals directly before joing MicroBiome. He has also served as CEO of Accera and is currently Chairman of the Colorado Institute for Drug, Device & Diagnostic Development.
MicroBiome’s Chairman, Dr. John Elstrott said: “We are delighted to welcome our new CEO, Steve Orndorff, whose extensive biotechnology and drug development experience will be critical as we progress the company to the next stage.”